These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25197510)

  • 41. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
    Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
    Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets.
    Chen Y; Wang W; Morgan MP; Robson T; Annett S
    Front Endocrinol (Lausanne); 2023; 14():1148934. PubMed ID: 37361533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
    Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
    Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis.
    Petrelli F; Manara M; Colombo S; De Santi G; Ghidini M; Mariani M; Iaculli A; Rausa E; Rampulla V; Arru M; Viti M; Lonati V; Ghidini A; Luciani A; Facciorusso A
    Neoplasia; 2022 Aug; 30():100809. PubMed ID: 35636146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
    Kodama K; Kawaguchi T; Hyogo H; Nakajima T; Ono M; Seike M; Takahashi H; Nozaki Y; Kawanaka M; Tanaka S; Imajo K; Sumida Y; Kamada Y; Fujii H; Seko Y; Takehara T; Itoh Y; Nakajima A; Masaki N; Torimura T; Saibara T; Karino Y; Chayama K; Tokushige K
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1626-1632. PubMed ID: 30668889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of hepatocellular carcinoma.
    Yu MC; Yuan JM; Govindarajan S; Ross RK
    Can J Gastroenterol; 2000 Sep; 14(8):703-9. PubMed ID: 11185536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical features and management issues of NAFLD-related HCC: what we know so far.
    Pugliese N; Alfarone L; Arcari I; Giugliano S; Parigi TL; Rescigno M; Lleo A; Aghemo A
    Expert Rev Gastroenterol Hepatol; 2023 Jan; 17(1):31-43. PubMed ID: 36576057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Khan FZ; Perumpail RB; Wong RJ; Ahmed A
    World J Hepatol; 2015 Aug; 7(18):2155-61. PubMed ID: 26328027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study.
    Duberg AS; Lybeck C; Fält A; Montgomery S; Aleman S
    Hepatol Commun; 2022 Sep; 6(9):2418-2430. PubMed ID: 35503810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
    Russo FP; Zanetto A; Pinto E; Battistella S; Penzo B; Burra P; Farinati F
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region.
    Waked I; Alsammany S; Tirmazy SH; Rasul K; Bani-Issa J; Abdel-Razek W; Omar A; Shafik A; Eid S; Abdelaal A; Hosni A; Esmat G
    Liver Int; 2023 Oct; 43(10):2062-2077. PubMed ID: 37553777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
    Seeff LB; Hoofnagle JH
    Oncogene; 2006 Jun; 25(27):3771-7. PubMed ID: 16799618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver disease.
    Taflin H; Hafström L; Holmberg E; Castedal M; Lindnér P
    Scand J Gastroenterol; 2019 Jun; 54(6):746-752. PubMed ID: 31190577
    [No Abstract]   [Full Text] [Related]  

  • 54. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
    Starley BQ; Calcagno CJ; Harrison SA
    Hepatology; 2010 May; 51(5):1820-32. PubMed ID: 20432259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
    Loomba R; Lim JK; Patton H; El-Serag HB
    Gastroenterology; 2020 May; 158(6):1822-1830. PubMed ID: 32006545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma.
    Gambarin-Gelwan M
    Chin Clin Oncol; 2013 Dec; 2(4):32. PubMed ID: 25841911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
    Meringer H; Shibolet O; Deutsch L
    World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B.
    Cho H; Chang Y; Lee JH; Cho YY; Nam JY; Lee YB; Lee DH; Cho EJ; Yu SJ; Kim YJ; Lee JM; Yoon JH
    J Clin Gastroenterol; 2020 Aug; 54(7):633-641. PubMed ID: 31033805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.
    Caldwell S; Park SH
    J Gastroenterol; 2009; 44 Suppl 19():96-101. PubMed ID: 19148801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma.
    Zhang C; Yang M
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.